Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max S Wicha

Showing results (191-200 of 209) with videos related to

Pageof 21
Sort By:
Oncotarget|February 18, 2015
Role of microRNA221 in regulating normal mammary epithelial hierarchy and breast cancer stem-like cellsJia Ke, Zhiju Zhao, Su-Hyung Hong, et al.
Cancer Research|July 19, 2017
Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung CancersVasudha Murlidhar, Rishindra M Reddy, Shamileh Fouladdel, et al.
Nature Communications|January 24, 2015
Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitorYing Liu, Chunying Chen, Pengxu Qian, et al.
Nature Immunology|March 25, 2026
Author Correction: Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathologyHideaki Fujiwara, Keisuke Seike, Michael D Brooks, et al.
Nature Immunology|October 23, 2021
Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathologyHideaki Fujiwara, Keisuke Seike, Michael D Brooks, et al.
Carcinogenesis|February 25, 2016
Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancerEn-Chi Hsu, Samuel K Kulp, Han-Li Huang, et al.
Stem Cell Reports|February 11, 2014
Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterpartsSuling Liu, Yang Cong, Dong Wang, et al.
Scientific Reports|March 18, 2015
A nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinomaQiu-Zhong Pan, Qi-Jing Wang, Jia-Qiang Dan, et al.
Nature Metabolism|September 21, 2022
Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancerAbhinav Achreja, Tao Yu, Anjali Mittal, et al.
Molecular Cancer Therapeutics|May 27, 2020
EMP2 Is a Novel Regulator of Stemness in Breast Cancer CellsChristen Dillard, Meagan Kiyohara, Vei Mah, et al.
Pageof 21

Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
Oncotarget|February 18, 2015
Role of microRNA221 in regulating normal mammary epithelial hierarchy and breast cancer stem-like cellsJia Ke, Zhiju Zhao, Su-Hyung Hong, et al.
Cancer Research|July 19, 2017
Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung CancersVasudha Murlidhar, Rishindra M Reddy, Shamileh Fouladdel, et al.
Nature Communications|January 24, 2015
Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitorYing Liu, Chunying Chen, Pengxu Qian, et al.
Nature Immunology|March 25, 2026
Author Correction: Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathologyHideaki Fujiwara, Keisuke Seike, Michael D Brooks, et al.
Nature Immunology|October 23, 2021
Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathologyHideaki Fujiwara, Keisuke Seike, Michael D Brooks, et al.
Carcinogenesis|February 25, 2016
Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancerEn-Chi Hsu, Samuel K Kulp, Han-Li Huang, et al.
Stem Cell Reports|February 11, 2014
Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterpartsSuling Liu, Yang Cong, Dong Wang, et al.
Scientific Reports|March 18, 2015
A nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinomaQiu-Zhong Pan, Qi-Jing Wang, Jia-Qiang Dan, et al.
Nature Metabolism|September 21, 2022
Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancerAbhinav Achreja, Tao Yu, Anjali Mittal, et al.
Molecular Cancer Therapeutics|May 27, 2020
EMP2 Is a Novel Regulator of Stemness in Breast Cancer CellsChristen Dillard, Meagan Kiyohara, Vei Mah, et al.
Pageof 21